Write to us if you want more detailed information about the project.
Adding HT to RT, even in elderly patients, is well tolerated and does not increase late toxicity
RT + HT can be a valid option to reducing the radiation dose without affecting the outcomes
RT combined with HT will be indicated particularly in case of paediatric tumours
Boosting the efficacy of RT+HT will increase the number of patients who are suitable for treatment
Increased dose can be delivered safely to large tumours thus improving the efficacy of treatments
RT + HT could be a viable treatment option for patients unsuitable for chemoradiotherapy